Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AMG 119 |
Synonyms | |
Therapy Description |
AMG 119 are autologous T-cells that have been engineered to express a chimeric antigen receptor (CAR) that targets DLL3, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (J of Thoracic Oncology. 2018, 13(Supplement), S971. P3.12-03). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMG 119 | AMG-119|AMG119 | AMG 119 are autologous T-cells that have been engineered to express a chimeric antigen receptor (CAR) that targets DLL3, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (J of Thoracic Oncology. 2018, 13(Supplement), S971. P3.12-03). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|